Financial Snapshot

Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$481.7K
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
0.07%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
-$2.178M
Q3 2024
Cash
Q3 2024
P/E
-54.69
Nov 25, 2024 EST
Free Cash Flow

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2007 2006
Revenue $17.78K $16.31K $4.500K $8.250K $1.125M $420.0K
YoY Change 9.01% 262.44% -45.45% 167.86%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2007 2006
Revenue $17.78K $16.31K $4.500K $8.250K $1.125M $420.0K
Cost Of Revenue $13.42K $11.65K $3.250K $6.000K $601.0K $200.0K
Gross Profit $4.360K $4.660K $1.250K $2.250K $524.0K $220.0K
Gross Profit Margin 24.52% 28.57% 27.78% 27.27% 46.58% 52.38%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2007 2006
Selling, General & Admin $472.0K $485.5K $502.0K $158.4M $50.90K $71.41K $32.52K $7.960K $3.174M $2.520M
YoY Change -2.79% -3.28% -99.68% 311115.25% -28.72% 119.59% 308.54% 25.95%
% of Gross Profit 1167.43% 1532.4% 2601.6% 353.78% 605.73% 1145.45%
Research & Development $1.145M $840.0K
YoY Change 36.31%
% of Gross Profit 218.51% 381.82%
Depreciation & Amortization $258.0K $200.0K
YoY Change 29.0%
% of Gross Profit 49.24% 90.91%
Operating Expenses $472.0K $485.5K $502.0K $158.4M $50.89K $71.40K $32.51K $7.960K $4.319M $3.360M
YoY Change -2.79% -3.28% -99.68% 311176.4% -28.73% 119.62% 308.42% 28.54%
Operating Profit -$472.0K -$485.5K -$502.0K -$158.4M -$46.53K -$66.74K -$31.26K -$5.710K -$3.795M -$3.140M
YoY Change -2.79% -3.28% -99.68% 340343.93% -30.28% 113.5% 447.46% 20.86%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2007 2006
Interest Expense $33.00K -$830.0K
YoY Change -103.98%
% of Operating Profit
Other Income/Expense, Net $0.00 -$1.000K
YoY Change -100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2007 2006
Pretax Income -$472.0K -$485.5K -$502.0K -$158.4M -$46.54K -$67.74K -$31.26K -$5.710K -$3.855M -$3.970M
YoY Change -2.79% -3.28% -99.68% 340270.78% -31.3% 116.7% 447.46% -2.9%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$472.0K -$485.5K -$502.0K -$158.4M -$46.54K -$67.74K -$31.26K -$5.710K -$3.855M -$3.970M
YoY Change -2.79% -3.28% -99.68% 340270.77% -31.3% 116.7% 447.46% -2.9%
Net Earnings / Revenue -261.75% -415.33% -694.67% -69.21% -342.67% -945.24%
Basic Earnings Per Share -$0.02 -$0.02
Diluted Earnings Per Share -$0.02 -$0.02 -$17.15K -$9.716M -$3.049K -$4.439K -$2.052K -$375.10 -$796.0K -$174.4K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2007 2006
Cash & Short-Term Investments $640.00 $730.00 $11.11K $39.87K $52.90K $29.39K $14.33K $14.33K $270.0K $2.600M
YoY Change -12.33% -93.43% -72.13% -24.63% 79.99% 105.09% 0.0% -89.62%
Cash & Equivalents $270.0K $2.600M
Short-Term Investments
Other Short-Term Assets $0.00 $40.00 $0.00 $6.000K $0.00 $2.080K $2.080K $150.0K $60.00K
YoY Change -100.0% -100.0% -100.0% 0.0% 150.0%
Inventory $1.050M $1.190M
Prepaid Expenses
Receivables $0.00 $5.740K $4.500K $0.00 $310.0K $20.00K
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $640.00 $730.00 $11.15K $39.87K $58.90K $35.13K $20.91K $16.41K $1.780M $3.870M
YoY Change -12.33% -93.45% -72.03% -32.31% 67.66% 68.01% 27.42% -54.01%
Property, Plant & Equipment $580.0K $540.0K
YoY Change 7.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.310M $1.190M
YoY Change 10.08%
Total Assets $640.00 $730.00 $11.15K $39.87K $58.90K $35.13K $20.91K $16.41K $3.090M $5.060M
YoY Change
Accounts Payable $2.650K $400.00 $6.310K $5.090K $10.25K $5.320K $12.71K $14.12K $310.0K $510.0K
YoY Change 562.5% -93.66% 23.97% -50.34% 92.67% -58.14% -9.99% -39.22%
Accrued Expenses $1.597M $1.174M $750.5K $327.5K $260.0K $190.0K
YoY Change 36.05% 56.36% 129.15% 36.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $90.00K $130.0K
YoY Change -30.77%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.820M $1.348M $873.0K $399.8K $11.59K $5.320K $12.71K $14.12K $700.0K $840.0K
YoY Change 35.0% 54.41% 118.38% 3349.27% 117.86% -58.14% -9.99% -16.67%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $160.0K $280.0K
YoY Change -42.86%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $160.0K $280.0K
YoY Change -42.86%
Total Liabilities $1.820M $1.348M $873.0K $399.8K $11.59K $5.320K $12.71K $14.12K $860.0K $1.120M
YoY Change 35.0% 54.41% 118.38% 3349.27% 117.86% -58.14% -9.99% -23.21%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2007 2006
Basic Shares Outstanding 29.27M shares 29.27M shares
Diluted Shares Outstanding 29.27M shares 29.27M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $26.345 Million

About BIOFORCE NANOSCIENCES HOLDINGS, INC.

BioForce Nanosciences Holdings, Inc. engages in the provision of natural vitamins, minerals and other nutritional supplements, powders and beverages, formulated to promote a healthier lifestyle for active individuals in all age ranges. The company is headquartered in Virginia Beach, Virginia and currently employs 3 full-time employees. The company went IPO on 2005-10-11. The firm markets its products through social media and telemarketing. The firm seeks to expand its BioForce Eclipse nutritional powder for use into households throughout the United States. Nutrition retailers, grocery stores, retail pharmacies, and online stores, like Amazon, focuses to be the channels for the Company’s Eclipse product lines. The firm private labels the powder through a manufacturer located in Virginia. The firm caters to the needs of customers with a focus on the elderly and athletes across numerous sports, ages, and economic backgrounds. The firm also focuses on offering its products for direct sales on its Website at www.bioforceeclipse.com. The Company’s wholly owned subsidiary is Element Global, Inc.

Industry: Laboratory Analytical Instruments Peers: LFTD PARTNERS INC. FITLIFE BRANDS, INC. ESTEE LAUDER COMPANIES INC UPEXI, INC. Healing Co Inc. NATURES SUNSHINE PRODUCTS INC REVLON INC /DE/ Thorne Healthtech, Inc.